Routine colonoscopy in patients with high risk of non-occlusive mesenteric ischemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Intensive care medicine. - 50, 7 (2024) , 1204-1205, ISSN: 1432-1238
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2024
- DOI
-
10.1007/s00134-024-07483-8
- URN
-
urn:nbn:de:bsz:25-freidok-2491211
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:42 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
Entstanden
- 2024
Ähnliche Objekte (12)
Non-occlusive mesenteric ischemia: the wolf in sheep’s clothing
Zellzyklus regulierende Funktion der Mammalian-STE20-like-Kinase-1 (MST1)
Zellzyklus regulierende Funktion der Mammalian-STE20-like-Kinase-1 (MST1)
Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP)—a single center, open-label, three-arm, randomized, controlled intervention trial
Correction: Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP) - a single center, open-label, three-arm, randomized, controlled intervention trial
Cytokine adsorption in patients with acute‐on‐chronic liver failure (CYTOHEP) — Aasingle center, open‐label, three‐arm, randomized, controlled intervention pilot trial
Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma : : a response‐based approach
HCC-Biomarker in der Diagnostik und Therapie des Hepatozellulären Karzinoms (HCC) in verschiedenen Phasen der Erkrankung
Practical considerations on hypoxemia and hypoxia in V-V ECMO patients
Comment on : : Extracorporeal hemoadsorption in critically ill COVID‑19 patients on VV ECMO
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
Non-occlusive mesenteric ischemia: the wolf in sheep’s clothing
Zellzyklus regulierende Funktion der Mammalian-STE20-like-Kinase-1 (MST1)
Zellzyklus regulierende Funktion der Mammalian-STE20-like-Kinase-1 (MST1)
Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP)—a single center, open-label, three-arm, randomized, controlled intervention trial
Correction: Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP) - a single center, open-label, three-arm, randomized, controlled intervention trial
Cytokine adsorption in patients with acute‐on‐chronic liver failure (CYTOHEP) — Aasingle center, open‐label, three‐arm, randomized, controlled intervention pilot trial
Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma : : a response‐based approach
HCC-Biomarker in der Diagnostik und Therapie des Hepatozellulären Karzinoms (HCC) in verschiedenen Phasen der Erkrankung
Practical considerations on hypoxemia and hypoxia in V-V ECMO patients
Comment on : : Extracorporeal hemoadsorption in critically ill COVID‑19 patients on VV ECMO
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
Non-occlusive mesenteric ischemia: the wolf in sheep’s clothing
Zellzyklus regulierende Funktion der Mammalian-STE20-like-Kinase-1 (MST1)
Zellzyklus regulierende Funktion der Mammalian-STE20-like-Kinase-1 (MST1)
Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP)—a single center, open-label, three-arm, randomized, controlled intervention trial
Correction: Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP) - a single center, open-label, three-arm, randomized, controlled intervention trial
Cytokine adsorption in patients with acute‐on‐chronic liver failure (CYTOHEP) — Aasingle center, open‐label, three‐arm, randomized, controlled intervention pilot trial
Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma : : a response‐based approach
HCC-Biomarker in der Diagnostik und Therapie des Hepatozellulären Karzinoms (HCC) in verschiedenen Phasen der Erkrankung
Practical considerations on hypoxemia and hypoxia in V-V ECMO patients
Comment on : : Extracorporeal hemoadsorption in critically ill COVID‑19 patients on VV ECMO
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma